Asan Medical Center Earns Highest Distinction in Newsweek’s Inaugural Green Hospital Rankings
Asan Medical Center has achieved the highest rating in U.S. news magazine Newsweek's assessment of environmentally sustainable hospitals, placing it...
Search results for "Aug. 17"
South Korea to Deploy AI Across Public Health Centers and Ambulances to Close Care Gaps
Artificial intelligence tools that assist in interpreting X-ray images and drafting clinical notes will soon be deployed to public health centers in...
Hanmi Control Dispute Reignites as Court Freezes 10 Billion Won in Lim Ju-hyun’s Shares
The "four-party alliance" formed to stabilize management control at Hanmi Pharmaceutical Group has descended into open...
Jeju Hanguk Hospital Marks 43rd Anniversary with Patient-Centric 'Back-to-Basics' Campaign
Patients evaluate a hospital by more than just clinical consultations and surgery. From an employee's initial greeting...
Alteogen Signs $365 Million Licensing Deal for Subcutaneous Drug Delivery Platform ALT-B4
Biotechnology firm Alteogen has signed an exclusive technology-transfer agreement worth up to $365 million...
6 in 10 Snakebite Victims Hospitalized: September Outdoor Work and Grave Tending Pose Highest Risk
As the annual grave-tending season returns ahead of Chuseok, health authorities are urging heightened caution against...
Keimyung University Dongsan Hospital Earns 11th Straight Top Rating for Acute Stroke Care
Keimyung University Dongsan Hospital announced on August 3 that it received the top Grade 1 rating in the Health...
How to Prevent Food Poisoning on Vacation: Handle Eggs and Raw Meat with Care
Peak summer vacation season is in full swing. While it is a time to unwind, it is also a period when people need to be...
Licensing Windfalls and Exports Split Performance Among Korea’s Top Drugmakers in Q2
South Korea’s five major legacy pharmaceutical companies largely extended their revenue growth in the second quarter,...
Scalp-Injected RNA Hair Loss Drug Completes Phase 1b Dosing in Australia
OliX announced on August 4 that it has completed patient dosing in the Australian Phase 1b clinical trial for OLX104C...